San Diego, CA, United States of America

Mark C Brister

USPTO Granted Patents = 191 

 

Average Co-Inventor Count = 4.9

ph-index = 55

Forward Citations = 20,383(Granted Patents)


Inventors with similar research interests:


Location History:

  • Forestville, CA (US) (2006 - 2009)
  • Encintas, CA (US) (2011)
  • Carlsbad, CA (US) (2019)
  • Cardiff, CA (US) (2020)
  • Eincinitas, CA (US) (2020)
  • Encinitas, CA (US) (2005 - 2024)
  • San Diego, CA (US) (2012 - 2024)

Company Filing History:


Years Active: 2005-2025

Loading Chart...
Loading Chart...
191 patents (USPTO):

Title: Mark Brister: Innovator in Continuous Analyte Sensors and Data Processing

Introduction:

In the world of continuous analyte sensors, Mark Brister has emerged as a prominent figure with his expertise in developing cutting-edge technologies. Hailing from Encinitas, California, Brister has filed an impressive total of 165 patents, solidifying his position as a leading innovator in the field. This article delves into Brister's latest patents, highlights his career achievements, explores his collaborations with renowned companies, and concludes by recognizing his significant contributions to the industry.

Latest Patents:

Among Brister's notable inventions is the development of a dual electrode system for a continuous analyte sensor. This breakthrough technology employs first and second working electrodes to measure additional analyte or non-analyte related signals. These measurements play a crucial role in providing background and sensitivity measurements for accurate processing of sensor data. Furthermore, they can trigger events such as digital filtering or suspending display of data, leading to improved accuracy and reliability of the continuous glucose sensor.

Another significant invention is Brister's system for replacing signal artifacts in a glucose sensor data stream. This groundbreaking method allows the detection of noise episodes and subsequent processing of analyte sensor data in response to such episodes. By effectively filtering out the effects of noise, the sensor data is refined, resulting in more precise measurements and better usability.

Career Highlights:

Mark Brister's career showcases an impressive array of achievements, with his expertise primarily focused on continuous glucose sensing technologies. His pivotal work in this area has significantly advanced the field, providing valuable insights and solutions to improve patient outcomes. Brister's impressive number of 165 filed patents reflects his unwavering commitment to innovation and his unremitting drive to push the boundaries of continuous analyte sensors.

Collaborations:

Throughout his career, Mark Brister has collaborated with renowned companies at the forefront of medical technologies. Notably, he has made significant contributions as an inventor at Dexcom, a leading company in the development of continuous glucose monitoring systems. Brister's expertise has played a vital role in advancing Dexcom's product offerings, enhancing their accuracy, and expanding their usability for diabetes patients worldwide.

Additionally, Brister has worked alongside talented colleagues such as Peter C. Simpson and Sean Saint, harnessing their collective expertise to drive innovation in the industry. These collaborative efforts have led to groundbreaking advancements, cementing Mark Brister's reputation as an invaluable asset within the field of continuous analyte sensors.

Conclusion:

Mark Brister has undoubtedly established himself as a trailblazer in the realm of continuous analyte sensors and data processing. With an impressive patent portfolio and a career marked by notable accomplishments, his contributions have significantly impacted the field, benefiting patients and pushing the boundaries of innovation. As the industry continues to evolve, it is clear that Mark Brister's dedication and ingenuity will shape the future of continuous analyte sensors, leading to improved healthcare outcomes for individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…